Gilead Sciences Inc (NASDAQ: GILD)
DRUGS - Biotechnology
Health Care
Stock price data as of
Closing price: $151.40
-
Support level$128.33
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)63.0
- GILD is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- GILD is one of this month's top performers with a return of 15.4 percent, beating 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $96.91 | $155.80 | 94.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $118.92 | $132.58 | $147.11 | $152.45 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week7.9%
-
In the next month15.7%
-
In the next year55.9%
| Period | Value |
|---|---|
| Historical (5 year) | 23.9% |
| Last month | 26.3% |
| Current estimate | 28.9% |
| Next month forecast | 27.8% |